Adaptive Biotechnologies Corp. (ADPT) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1234884,
    "name": "Adaptive Biotechnologies Corp.",
    "stock_name": "Adaptive Biotechnologies Corp.",
    "full_name": "Adaptive Biotechnologies Corp.",
    "name_url": "stocks-analysis/adaptive-biotechnologies-corp",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "17.46",
    "chg": -1.23,
    "chgp": "-6.58%",
    "dir": -1,
    "prev_price": "18.69",
    "mcapval": "1,909.52",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "US00650F1093",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "1.98 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/adaptive-biotechnologies-corp-1234884-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Adaptive Biotechnologies Hits Day High with 9.82% Surge in Stock Price",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/adaptive-biotechnologies-hits-day-high-with-982-surge-in-stock-price-3626737",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/AdaptiveBiotech_priceRelatedfactors_3626737.png",
        "date": "2025-10-16 19:03:47",
        "description": "Adaptive Biotechnologies Corp. has seen notable stock activity, achieving significant gains over various timeframes, including a remarkable annual increase. The company reported strong quarterly net sales and a reduction in raw material costs, while maintaining full institutional ownership, reflecting investor confidence in its market position within the biotechnology sector."
      },
      {
        "title": "Adaptive Biotechnologies Corp. Hits New 52-Week High of $17.14",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/adaptive-biotechnologies-corp-hits-new-52-week-high-of-1714-3626655",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/AdaptiveBiotech_priceRelatedfactors_3626655.png",
        "date": "2025-10-16 18:25:08",
        "description": "Adaptive Biotechnologies Corp. achieved a new 52-week high of USD 17.14 on October 15, 2025, marking significant growth from its previous low. The company, with a market cap of USD 1,910 million, has shown a remarkable one-year performance, despite remaining in a loss-making position."
      },
      {
        "title": "Adaptive Biotechnologies Corp. Hits New 52-Week High of $15.94",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/adaptive-biotechnologies-corp-hits-new-52-week-high-of-1594-3620145",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/AdaptiveBiotech_priceRelatedfactors_3620145.png",
        "date": "2025-10-14 18:55:02",
        "description": "Adaptive Biotechnologies Corp. achieved a new 52-week high of USD 15.94 on October 13, 2025, reflecting significant growth from its previous low. Operating in the Pharmaceuticals & Biotechnology sector, the company has shown impressive performance over the past year, despite being loss-making and lacking a dividend yield."
      },
      {
        "title": "Adaptive Biotechnologies Hits Day High with 8.36% Surge in Stock Price",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/adaptive-biotechnologies-hits-day-high-with-836-surge-in-stock-price-3608140",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/AdaptiveBiotech_priceRelatedfactors_3608140.png",
        "date": "2025-10-09 21:00:45",
        "description": "Adaptive Biotechnologies Corp. has shown notable stock performance, with significant gains over the past month and year, outpacing the S&P 500. The company reported its highest quarterly net sales and reduced raw material costs, although it faces challenges with negative EBITDA and a high debt-to-equity ratio."
      },
      {
        "title": "Adaptive Biotechnologies Corp. Hits New 52-Week High of $15.57",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/adaptive-biotechnologies-corp-hits-new-52-week-high-of-1557-3608044",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/AdaptiveBiotech_priceRelatedfactors_3608044.png",
        "date": "2025-10-09 20:21:43",
        "description": "Adaptive Biotechnologies Corp. achieved a new 52-week high of USD 15.57 on October 8, 2025, reflecting significant growth from its previous low. The company, with a market cap of USD 1,910 million, has shown a remarkable one-year performance, despite being in a loss-making position and having a unique financial structure."
      },
      {
        "title": "Adaptive Biotechnologies Corp. Hits New 52-Week High of $15.26",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/adaptive-biotechnologies-corp-hits-new-52-week-high-of-1526-3588399",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/AdaptiveBiotech_priceRelatedfactors_3588399.png",
        "date": "2025-10-02 22:39:14",
        "description": "Adaptive Biotechnologies Corp. achieved a new 52-week high of USD 15.26 on October 1, 2025, reflecting a substantial increase over the past year. Despite its strong stock performance, the company operates at a loss, with a high price-to-book ratio indicating a premium valuation in the biotechnology sector."
      },
      {
        "title": "Adaptive Biotechnologies Corp. Hits New 52-Week High at $15.04",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/adaptive-biotechnologies-corp-hits-new-52-week-high-at-1504-3586066",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/AdaptiveBiotech_priceRelatedfactors_3586066.png",
        "date": "2025-10-01 16:42:25",
        "description": "Adaptive Biotechnologies Corp. has achieved a new 52-week high, reflecting a significant performance increase over the past year. The company, with a market capitalization of USD 1,910 million, shows strong momentum in the Pharmaceuticals & Biotechnology sector despite being loss-making and lacking a dividend yield."
      },
      {
        "title": "Adaptive Biotechnologies Hits Day High with 13.94% Surge in Stock Price",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/adaptive-biotechnologies-hits-day-high-with-1394-surge-in-stock-price-3585910",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/AdaptiveBiotech_priceRelatedfactors_3585910.png",
        "date": "2025-10-01 16:19:10",
        "description": "Adaptive Biotechnologies Corp. has seen a notable rise in stock performance, achieving a significant annual growth rate. The company reported record net sales and reduced raw material costs, although it faces challenges with negative EBITDA and a specific debt-to-equity ratio. High institutional holdings indicate strong investor support."
      },
      {
        "title": "Adaptive Biotechnologies Stock Hits Day Low of $12.72 Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/adaptive-biotechnologies-stock-hits-day-low-of-1272-amid-price-pressure-3571239",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/AdaptiveBiotech_priceRelatedfactors_3571239.png",
        "date": "2025-09-25 16:36:12",
        "description": "Adaptive Biotechnologies Corp. saw a significant stock decline today, reaching an intraday low. Despite this, the company has demonstrated strong performance metrics over the past year, including substantial net sales and reduced raw material costs. However, it faces challenges such as negative EBITDA and a high debt-to-equity ratio."
      }
    ],
    "total": 21,
    "sid": "1234884",
    "stock_news_url": "https://www.marketsmojo.com/news/adaptive-biotechnologies-corp-1234884"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Adaptive Biotechnologies Hits Day High with 9.82% Surge in Stock Price

2025-10-16 19:03:47

Adaptive Biotechnologies Corp. has seen notable stock activity, achieving significant gains over various timeframes, including a remarkable annual increase. The company reported strong quarterly net sales and a reduction in raw material costs, while maintaining full institutional ownership, reflecting investor confidence in its market position within the biotechnology sector.

Adaptive Biotechnologies Corp. Hits New 52-Week High of $17.14

2025-10-16 18:25:08

Adaptive Biotechnologies Corp. achieved a new 52-week high of USD 17.14 on October 15, 2025, marking significant growth from its previous low. The company, with a market cap of USD 1,910 million, has shown a remarkable one-year performance, despite remaining in a loss-making position.

Adaptive Biotechnologies Corp. Hits New 52-Week High of $15.94

2025-10-14 18:55:02

Adaptive Biotechnologies Corp. achieved a new 52-week high of USD 15.94 on October 13, 2025, reflecting significant growth from its previous low. Operating in the Pharmaceuticals & Biotechnology sector, the company has shown impressive performance over the past year, despite being loss-making and lacking a dividend yield.

Adaptive Biotechnologies Hits Day High with 8.36% Surge in Stock Price

2025-10-09 21:00:45

Adaptive Biotechnologies Corp. has shown notable stock performance, with significant gains over the past month and year, outpacing the S&P 500. The company reported its highest quarterly net sales and reduced raw material costs, although it faces challenges with negative EBITDA and a high debt-to-equity ratio.

Adaptive Biotechnologies Corp. Hits New 52-Week High of $15.57

2025-10-09 20:21:43

Adaptive Biotechnologies Corp. achieved a new 52-week high of USD 15.57 on October 8, 2025, reflecting significant growth from its previous low. The company, with a market cap of USD 1,910 million, has shown a remarkable one-year performance, despite being in a loss-making position and having a unique financial structure.

Adaptive Biotechnologies Corp. Hits New 52-Week High of $15.26

2025-10-02 22:39:14

Adaptive Biotechnologies Corp. achieved a new 52-week high of USD 15.26 on October 1, 2025, reflecting a substantial increase over the past year. Despite its strong stock performance, the company operates at a loss, with a high price-to-book ratio indicating a premium valuation in the biotechnology sector.

Adaptive Biotechnologies Corp. Hits New 52-Week High at $15.04

2025-10-01 16:42:25

Adaptive Biotechnologies Corp. has achieved a new 52-week high, reflecting a significant performance increase over the past year. The company, with a market capitalization of USD 1,910 million, shows strong momentum in the Pharmaceuticals & Biotechnology sector despite being loss-making and lacking a dividend yield.

Adaptive Biotechnologies Hits Day High with 13.94% Surge in Stock Price

2025-10-01 16:19:10

Adaptive Biotechnologies Corp. has seen a notable rise in stock performance, achieving a significant annual growth rate. The company reported record net sales and reduced raw material costs, although it faces challenges with negative EBITDA and a specific debt-to-equity ratio. High institutional holdings indicate strong investor support.

Adaptive Biotechnologies Stock Hits Day Low of $12.72 Amid Price Pressure

2025-09-25 16:36:12

Adaptive Biotechnologies Corp. saw a significant stock decline today, reaching an intraday low. Despite this, the company has demonstrated strong performance metrics over the past year, including substantial net sales and reduced raw material costs. However, it faces challenges such as negative EBITDA and a high debt-to-equity ratio.

View All News